Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-3.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dyadic International (DYAI) Common Equity (2017 - 2026)

Dyadic International's (DYAI) quarterly Common Equity came in at -$407732.0 in Q1 2026, down 144.15% year-over-year from $923611.0 in Q1 2025, and down 100.41% quarter-over-quarter from $100.0 million in Q4 2025.

Analysis

Dyadic International (DYAI) Common Equity (2017 - 2026) Analysis & Trends

Dyadic International has disclosed Common Equity across 10 years of filings, most recently posting -$407732.0 for Q1 2026.

  • In Q1 2026, Common Equity fell 144.15% year-over-year to -$407732.0; the TTM figure through Mar 2026 stood at -$407732.0 (down 144.15% YoY), while the FY2025 annual figure was $100.0 million, up 3948.11% from the prior year.
  • Common Equity came in at -$407732.0 for Q1 2026 at Dyadic International, down from $100.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $100.0 million in Q4 2025 to a low of -$529701.0 in Q2 2025.
  • Average Common Equity over 5 years is $11.9 million, with a median of $5.9 million recorded in 2023.
  • Year-over-year, Common Equity surged 3948.11% in 2025 and plunged 144.15% in 2026.
  • Over 5 years, Common Equity stood at $11.1 million in 2022, then sank by 46.98% to $5.9 million in 2023, then plunged by 57.98% to $2.5 million in 2024, then surged by 3948.11% to $100.0 million in 2025, then tumbled by 100.41% to -$407732.0 in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were -$407732.0 in Q1 2026, $100.0 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 11.69 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.83 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 20.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 31.71 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 8.42 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 6.76 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.35 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 18.85 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 4.92 Bn
10 Dyadic International 17.78 Mn 9.82 Mn - -407,732.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -407,732.00
Dec 31, 2025 100.00 Mn
Sep 30, 2025 2.61 Mn
Jun 30, 2025 -529,701.00
Mar 31, 2025 923,611.00
Dec 31, 2024 2.47 Mn
Sep 30, 2024 3.41 Mn
Jun 30, 2024 3.17 Mn
Mar 31, 2024 4.52 Mn
Dec 31, 2023 5.88 Mn
Sep 30, 2023 7.65 Mn
Jun 30, 2023 8.99 Mn
Mar 31, 2023 10.80 Mn
Dec 31, 2022 11.09 Mn
Sep 30, 2022 12.61 Mn
Jun 30, 2022 13.56 Mn
Mar 31, 2022 16.39 Mn
Dec 31, 2021 18.39 Mn
Sep 30, 2021 21.90 Mn
Jun 30, 2021 23.16 Mn